There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

The persistent COVID-19 pandemic since 2020 has brought an enormous public health
burden to the global society and is accompanied by various evolution of the virus genome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections in
vaccinated individuals and reinfections in previously infected individuals have become …

The emerging SARS-CoV-2 variants, commonly with many mutations in S1 subunit of spike
(S) protein are weakening the efficacy of the current vaccines and antibody therapeutics …

Infection with SARS-CoV-2 results in clinical outcomes ranging from silent or benign
infection in most individuals to critical pneumonia and death in a few. Genetic studies in …

The Omicron variant rapidly became the dominant SARS‐CoV‐2 strain in South Africa and
elsewhere. This review explores whether this rise was due to an increased transmission of …

The massive scale of the global SARS-CoV-2 sequencing effort created new opportunities
and challenges for understanding SARS-CoV-2 evolution. Rapid detection and assessment …

Abstract The Omicron variant (B. 1.1. 529) of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) extensively escapes neutralizing antibodies elicited by SARS-CoV-2 …

Vaccination programs against SARS-CoV-2 constitute the mainstay of public health
interventions against the global COVID-19 pandemic. Currently available vaccines have …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs)
have been key drivers of new coronavirus disease 2019 (COVID-19) pandemic waves. To …